Treatment of obstructive hypertrophic cardiomyopathy: the role of modern imaging and the place of surgery in the era of myosin inhibitors
Open Access
- 8 July 2026
- journal article
- Published by Zaporizhzhia State Medical and Pharmaceutical University in Zaporozhye Medical Journal
- Vol. 28 (4) , 358-364
Abstract
Aim. To evaluate modern approaches to preoperative planning of septal myectomy in patients with obstructive hypertrophic cardiomyopathy (HCM), to define the role of multimodality imaging (echocardiography, magnetic resonance imaging (MRI), computed tomography (CT)) and the place of surgical treatment in the era of rapid development and clinical implementation of selective myosin inhibitors. Materials and methods. An analytical review of current clinical guidelines, results of major clinical trials on myosin inhibitors, and fundamental publications on the principles of radiological planning and surgical techniques in obstructive HCM was performed. A literature search was conducted in PubMed, Scopus, and Google Scholar databases with the following keywords: hypertrophic cardiomyopathy, septal myectomy, preoperative planning, cardiac CT, cardiac MRI, myosin inhibitors. Results. Modern multimodality imaging represents an essential stage of preoperative assessment, providing the surgeon with the ability to optimally plan the extent of resection, minimize cardiopulmonary bypass time, and significantly reduce postoperative complications. Although myosin inhibitors demonstrate a marked reduction in left ventricular outflow tract gradients and improvement in clinical status – the complex morphological nature of obstruction, involving papillary muscles, subvalvular structures of the mitral valve, and systolic anterior motion of the anterior leaflet of the mitral valve – often limits the possibility of complete correction by medical therapy alone. Conclusions. Septal myectomy, when performed in highly specialized expert centers, remains the gold standard for patients with symptomatic obstructive HCM refractory to optimal medical therapy. The success and safety of this intervention are directly correlated with the precision and detail of preoperative planning, based on the modern cardiac imaging arsenal.Keywords
This publication has 40 references indexed in Scilit:
- Contemporary surgical treatment of hypertrophic obstructive cardiomyopathy: insights from the Ukrainian National Referral CenterIndian Journal of Thoracic and Cardiovascular Surgery, 2025
- Photon-counting CT myocardial extracellular volume: A non-invasive biomarker for fibrosis in patients with hypertrophic cardiomyopathyDiagnostic and Interventional Imaging, 2025
- Major adverse cardiovascular events after modified morrow surgery in hypertrophic obstructive cardiomyopathy: A 12-year cohort studyInternational Journal of Cardiology, 2024
- Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4Journal of Cardiac Failure, 2024
- Role of Imaging in the Diagnosis, Evaluation, and Management of Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2024
- Does a standard myectomy exist for obstructive hypertrophic cardiomyopathy? From the Morrow variations to precision surgeryInternational Journal of Cardiology, 2022
- Sixty-Year Evolution of Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy with Insights From the Historic NIH Surgical Experience to PresentThe American Journal of Cardiology, 2022
- Outcomes Over Follow-up ≥10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2022
- Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart TeamInternational Journal of Cardiology, 2020
- Role of Preoperative Cardiovascular Magnetic Resonance in Planning Ventricular Septal Myectomy in Patients With Obstructive Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2019